Lindsay Rocco | Elixir Health, Public Relations |
John Johnson | Chief Executive Officer |
Fred Cohen | Chief Medical Officer |
Rob Lutz | Chief Financial Officer |
Scott Wilhoit | Chief Commercial Officer |
Rich Kollender | Chief Operating Officer |
Chris Howerton | Jefferies |
Hartaj Singh | Oppenheimer and Company |
Avatar Jones | Stifel |
Jonathan Wolleben | JMP Securities |
Ladies and gentlemen, thank you for standing by and welcome to Strongbridge Biopharma’s Second Quarter 2020 Earnings Conference Call. At this time, all participants lines are in a listen only mode. [Operator Instructions]. I’d now like to hand the conference over to your speaker today, Lindsay Rocco of Elixir Health Public Relations. Thank you and please go ahead, ma’am.